Insulcloud
Diabetes under control
Who we are
Insulcloud is a Spanish company whose main mission is to improve the quality and life expectancy of people with diabetes.
We develop digital health solutions that empower patients with diabetes to better manage their condition.
In addition, we support healthcare professionals in improving their daily clinical practice, optimizing the efficiency of healthcare resources.
What is the Insulcloud 360® System?
A system that integrates all essential diabetes data in real time for efficient management of patients with diabetes.
The Insulcloud 360® System consists of three main elements:
- 1CAP Insulclock® by Insulcloud, for real-time monitoring of disposable insulin pen use.
- 2Diabetes Control App - Insulclock 360® by Insulcloud, for data integration by the patient: insulin, glucose, exercise, food.
- 3ENDO® Platform by Insulcloud, created by healthcare professionals to facilitate daily clinical practice with diabetes patients.
ENDO® by Insulcloud
The platform that simplifies diabetes patient management.
Continuous and efficient monitoring
On one screen, all data for monitoring and controlling your patients' diabetes:
- Insulin administered
- Glucose and AGP
- Time in range
- Therapeutic adherence
- Nutrition
Real-time follow-up
All data is updated immediately, allowing healthcare professionals to make informed decisions.
Integration with clinical records
Data integration speeds up and improves care quality, providing centralized access to comprehensive diabetes information.
Request a free demo
contact
Clinical trials and publications
Diabetes Care
Efficacy of a Connected Insulin Pen Cap in People With Noncontrolled Type 1 Diabetes: A Multicenter Randomized Clinical Trial
Emory University School of Medicine
A Randomized Study To Evaluate The Efficacy Of Insulclock® Pen Device In Insulin-treated Patients With Uncontrolled Type 2 Diabetes
European Patent Office
Monitoring device with universal adapter to drug injection pens
2020 ATTD Congress
Improvement in glycemic control, adherence and quality of life in patients with T1D
2019 ATTD Congress
Monitoring of dose, timing and missed insulin injections. Helps detect and avoid common insulin administration errors
Diabetes Technology & Therapeutics
Insulclock: A Novel Insulin Delivery Optimization and Tracking System
Awards & collaborations
II Health Challenge Andalusia
Insulclock wins the II Health Challenge Andalusia for its Integrated Assistance System for diabetes management.
Jiménez Díaz Foundation
Integration of the Insulclock System in the University Hospital of the Fundación Jiménez Díaz, Quirón Salud Group.
Innovative SME - MICINN
Recognized as Innovative SME by the Ministry of Economy and Business.
Universal Concentrator Assisted by Online Recommendation Technology (2022-2025)
Reference: CPP2021-009139. Funded by MICIN - €1,568,129.80. P.I. Luis Ruiz-Valdepeñas. Others: MiceLab - University of Girona
Horizon 2020
European Union recognition as one of the most innovative projects for diabetes control and monitoring.
IOT STARS AWARD
Winners of the IOT STARS AWARD at the Mobile World Congress.
NEOTEC
Support for the creation and consolidation of technology-based companies.
Development of a system to personalize and automate insulin treatment (2023-2025).
Co-financed by the European Regional Development Fund (FEDER 2021-2027) and CDTI - €894,034.
